A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma
Public ClinicalTrials.gov record NCT00395070. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Treatment With 2 mg Intralesional Allovectin-7® Compared to Dacarbazine (DTIC) or Temozolomide (TMZ) in Subjects With Recurrent Metastatic Melanoma
Study identification
- NCT ID
- NCT00395070
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Vical
- Industry
- Enrollment
- 390 participants
Conditions and interventions
Conditions
Interventions
- Allovectin-7® Biological
- Dacarbazine (DTIC) Drug
- Temozolomide (TMZ) Drug
Biological · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2006
- Primary completion
- Feb 29, 2012
- Completion
- Jun 30, 2013
- Last update posted
- Sep 12, 2013
2006 – 2013
United States locations
- U.S. sites
- 27
- U.S. states
- 18
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Location #40 | Tucson | Arizona | 85724 | — |
| Location #9 | Little Rock | Arkansas | 72205 | — |
| Location #1 | Bakersfield | California | 93309 | — |
| Location #24 | San Diego | California | 92093 | — |
| Location #36 | San Diego | California | 92161 | — |
| Location #47 | San Francisco | California | 94117 | — |
| Location #16 | Denver | Colorado | 80045 | — |
| Location #11 | Lakeland | Florida | 33805 | — |
| Location #7 | Chicago | Illinois | 60068 | — |
| Location #33 | Chicago | Illinois | 60612 | — |
| Location #20 | Louisville | Kentucky | 40202 | — |
| Location #35 | Baltimore | Maryland | 21202 | — |
| Location #4 | Kansas City | Missouri | 64111 | — |
| Location #19 | St Louis | Missouri | 63110 | — |
| Location #38 | Hackensack | New Jersey | 07601 | — |
| Location #8 | Montclair | New Jersey | 07042 | — |
| Location #87 | Albuquerque | New Mexico | 87131 | — |
| Location #41 | Cincinnati | Ohio | 45219 | — |
| Location #23 | Cleveland | Ohio | 44106 | — |
| Location #34 | Portland | Oregon | 97239 | — |
| Location #12 | Bethlehem | Pennsylvania | 18015 | — |
| Location #97 | Providence | Rhode Island | 02903 | — |
| Location #28 | Dallas | Texas | 75246 | — |
| Location #117 | Houston | Texas | 77030 | — |
| Location #27 | Salt Lake City | Utah | 84103 | — |
| Location #26 | Salt Lake City | Utah | 84112 | — |
| Location #32 | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 61 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00395070, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 12, 2013 · Synced Jul 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00395070 live on ClinicalTrials.gov.